# Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan

> **NCT04237493** · PHASE4 · COMPLETED · sponsor: **University of Jordan** · enrollment: 687 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Metformin and Glimepiride (Low Dosage)
- **DRUG:** Metformin and Vildagliptin (Low Dosage)
- **DRUG:** Metformin and Insulin Glargine U100 (Low Dosage)
- **DRUG:** Metformin, Insulin Glargine U100, and Human Regular Insulin (Low Dosage)
- **DRUG:** Metformin and Glimepiride (Regular Dosage)
- **DRUG:** Metformin and Vildagliptin (Regular Dosage)
- **DRUG:** Metformin and Insulin Glargine U100 (Regular Dosage)
- **DRUG:** Metformin, Insulin Glargine U100, and Human Regular Insulin (Regular Dosage)

## Key facts

- **NCT ID:** NCT04237493
- **Lead sponsor:** University of Jordan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-14
- **Primary completion:** 2017-07-24
- **Final completion:** 2017-07-24
- **Target enrollment:** 687 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04237493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04237493, "Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04237493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*